SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 242 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.33 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $5,083 | -21.6% | 190 | 0.0% | 0.00% | 0.0% |
| Q1 2024 | $6,481 | +17.9% | 190 | 0.0% | 0.00% | 0.0% |
| Q4 2023 | $5,499 | +5.0% | 190 | 0.0% | 0.00% | 0.0% |
| Q3 2023 | $5,238 | -8.3% | 190 | 0.0% | 0.00% | -33.3% |
| Q2 2023 | $5,711 | -17.0% | 190 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $6,884 | +1.6% | 190 | 0.0% | 0.00% | -25.0% |
| Q4 2022 | $6,777 | +13.0% | 190 | 0.0% | 0.00% | +33.3% |
| Q3 2022 | $6,000 | +20.0% | 190 | 0.0% | 0.00% | +50.0% |
| Q2 2022 | $5,000 | -16.7% | 190 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $6,000 | 0.0% | 190 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $6,000 | +20.0% | 190 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $5,000 | +25.0% | 190 | 0.0% | 0.00% | -33.3% |
| Q4 2019 | $4,000 | – | 190 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 379,533 | $9,386,000 | 6.98% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 1,022,940 | $25,297,000 | 3.79% |
| ASHFORD CAPITAL MANAGEMENT INC | 642,594 | $15,891,000 | 3.27% |
| Ranger Investment Management | 1,491,835 | $36,893,000 | 2.64% |
| AlphaOne Investment Services, LLC | 210,856 | $5,215,000 | 1.71% |
| NORTHPOINTE CAPITAL LLC | 615,061 | $15,210,000 | 1.58% |
| INSIGHT CAPITAL RESEARCH & MANAGEMENT INC | 141,485 | $3,499,000 | 1.56% |
| FALCON POINT CAPITAL, LLC | 454,002 | $8,989,000 | 1.38% |
| Iguana Healthcare Management, LLC | 300,000 | $7,420,000 | 1.32% |
| KOPP INVESTMENT ADVISORS LLC | 46,839 | $1,158,000 | 1.14% |